CHILDS JOHN W
SEC Form 4 insider trading activity
CHILDS JOHN W has filed 5 SEC Form 4 filings (10 transaction rows) across 2 companies, including MANE, BHVN, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, CHILDS JOHN W is listed as Director at Veradermics, Inc. Inside the rolling window, CHILDS JOHN W reported 3 open-market purchases totaling $30.9M in BHVN and MANE and 1 open-market sale totaling $10.7M in MANE. The largest disclosed transaction in the window is a purchase of 3,333,333 BHVN shares on Nov 13, 2025, worth $25.0M.
Companies traded
Other insiders at MANE
Insider Buying
$30.9M
reported purchases (SEC code P)
Insider Selling
$10.7M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has CHILDS JOHN W made?
CHILDS JOHN W has filed 5 SEC Form 4 filings (10 transaction rows) across 2 companies, including MANE, BHVN since 2025.
Which companies does CHILDS JOHN W trade?
CHILDS JOHN W has filed SEC Form 4 disclosures for 2 companies, including MANE, BHVN.
When was CHILDS JOHN W's most recent SEC Form 4 filing?
CHILDS JOHN W's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is CHILDS JOHN W's total buy and sell value in the current window?
Inside the rolling retention window, CHILDS JOHN W bought $30.9M and sold $10.7M based on SEC Form 4 filings.
What was CHILDS JOHN W's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,333,333 BHVN shares on 2025-11-13, worth $25.0M, per SEC Form 4 filings.